Sort by
Refine Your Search
-
Category
-
Country
-
Field
-
, University of Glasgow, University of Liverpool and University of Manchester) and four industry partners (GSK, AstraZeneca, Optum and Hammersmith Medicines Research) will provide a unique powerfully synergistic
-
We have an exciting opportunity for a Postdoctoral Researcher who wants to drive research into novel cancer therapeutics with the potential to impact human health, to join the group of Dr Joseph
-
to drive research into novel cancer therapeutics with the potential to impact human health, to join the group of Dr Joseph Newman at Centre for Medicines Discovery, Nuffield Department of Medicine. You will
-
), the ETH Zurich (Switzerland), AstraZeneca AB (Sweden) and EATRIS ERIC (Netherlands). ICHB joined this ongoing project with its own budget under the Hop-on Facility (EDITSCD-HOP-ON). Project description
-
to apply for the EACR-AstraZeneca Postdoctoral Fellowship, for which no more than 8 years can have elapsed since the Ph.D. defence. However, the lab has secured funding for at least 1 year, so the selected
-
(France), the ETH Zurich (Switzerland), AstraZeneca AB (Sweden) and EATRIS ERIC (Netherlands). ICHB will join this ongoing project with its own budget under the Hop-on Facility (EDITSCD-HOP-ON). Project
-
18380BR College of Arts, Humanities & Social Sciences Managerial, Professional and Specialist Staff – MPSS Advert Senior Data and Infrastructure Technician (Security, Crime and Intelligence
-
including Heptares Therapeutics and Galapagos NV, as well as consolidating links to the pharmaceutical giant AstraZeneca, resulting in enhanced funding and joint publications. By linking small molecule